Skip to main content
Irwin Naturals Inc. logo

Irwin Naturals Inc. — Investor Relations & Filings

Ticker · IWIN ISIN · CA46414Q1054 LEI · 9845003CF0B7JE8FAX54 CSE Manufacturing
Filings indexed 255 across all filing types
Latest filing 2020-06-02 Regulatory Filings
Country CA Canada
Listing CSE IWIN

About Irwin Naturals Inc.

https://irwinnaturals.com/

Irwin Naturals Inc. is a nutraceutical company focused on developing and distributing premium health supplements and vitamins. The company specializes in soft-gel based herbal formulas, prioritizing superior potency, bioavailability, and absorption. Its product portfolio includes targeted formulas for general wellness, sleep, cognitive function, detoxification, and weight management, alongside a range of CBD and THC products. A core unique selling proposition is the utilization of an all-liquid soft-gel delivery system combined with the signature BioPerine Complex, which is designed to enhance nutrient uptake. Irwin Naturals distributes its extensive line of supplements through mass-market and health food chain retailers across North America.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification by the Chief Financial Officer regarding the interim financial report and interim MD&A for the period ended March 31, 2020. It is a Form 52-109FV2 Certification of Interim Filings for a venture issuer. The content is primarily an officer certification attesting to the accuracy and fair presentation of the interim filings, without containing actual financial data or the interim report itself. According to the Certification Rule, such certifications should be classified as Regulatory Filings (RNS), not as the interim report (IR) itself.
2020-06-02 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification letter by the CEO regarding the review and fair presentation of the interim financial report and interim MD&A for the period ended March 31, 2020. It explicitly states it is a 'Venture Issuer Basic Certificate' under National Instrument 52-109, which is a certification of interim filings. The document does not contain the interim financial statements or substantive financial data itself, but rather a certification of those filings. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the interim report itself (IR). The document length is short (3003 characters), and it is a certification letter, not the actual interim report. Therefore, the correct classification is Regulatory Filings (RNS).
2020-06-02 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification by the Chief Financial Officer regarding the interim financial report and interim MD&A for the period ended March 31, 2020. It is a Venture Issuer Basic Certificate under Form 52-109FV2, which is a certification of interim filings. The document does not contain actual financial data or substantive financial analysis but is an attestation about the interim filings. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the interim report itself (IR). The document length is short (2973 characters), and it is primarily a certification letter, not the interim report or MD&A itself.
2020-06-02 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification statement by the CEO regarding the review and fair presentation of the interim financial report and interim MD&A for the period ended March 31, 2020. It is a Form 52-109FV2 Certification of Interim Filings for a venture issuer. The content is primarily an officer certification letter confirming the accuracy and completeness of the interim filings, without containing actual financial data or substantive financial analysis itself. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than as the interim report (IR) itself. The document length is short (3003 characters), and it does not contain the interim financial statements or detailed financial data, only the certification of those filings. Therefore, the correct classification is Regulatory Filings (RNS).
2020-06-02 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'CONDENSED INTERIM FINANCIAL STATEMENTS For the Three Months Ended March 31, 2020 and 2019' and contains detailed unaudited financial statements including statements of financial position, loss, changes in equity, cash flows, and notes. It explicitly states it is prepared under IAS 34 Interim Financial Reporting and covers a quarterly period. The document is 12,746 characters long, which is substantial and contains actual financial data and analysis, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2020
2020-06-02 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Management Discussion and Analysis For the three months ended March 31, 2020' and contains detailed financial results, operational commentary, liquidity and capital resources information, and forward-looking statements. It includes substantive financial data and analysis for a quarterly period, specifically the first quarter of 2020. The document is over 10,000 characters, indicating it is a full report rather than a brief announcement. It is not a certification or attestation letter, nor is it a simple announcement of report publication. The content matches the definition of an Interim / Quarterly Report (IR), which includes comprehensive financial data and management discussion for a period shorter than a full fiscal year. Q1 2020
2020-06-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.